Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Valuable Targets
5 min read
Nemesis of Hypercholesterolemia - CETP inhibitors
17 September 2023
CETP, or Cholesteryl Ester Transfer Protein, plays a crucial role in lipid metabolism within the human body.
Drug Insights
4 min read
Deep Scientific Insights on Triazolam's R&D Progress, Mechanism of Action, and Drug Target
17 September 2023
This article summarized the latest R&D progress of Triazolam, the Mechanism of Action for Triazolam, and the drug target R&D trends for Triazolam.
Latest Hotspot
3 min read
MBX Biosciences declares encouraging data from a Phase 1 Multiple Ascending Dose study for MBX 2109
17 September 2023
MBX Biosciences, Inc. released favorable outcomes from the Phase 1 trial's multiple ascending dose section for MBX 2109.
Drug Insights
4 min read
An In-depth Analysis of Tioconazole's R&D Progress and Mechanism of Action on Drug Target
17 September 2023
This article summarized the latest R&D progress of Tioconazole, the Mechanism of Action for Tioconazole, and the drug target R&D trends for Tioconazole.
Valuable Targets
6 min read
Star of transcriptional pathway potential: CDK9 inhibitor
17 September 2023
CDK9, also known as cyclin-dependent kinase 9, plays a crucial role in the regulation of gene expression and cell cycle progression in the human body.
Drug Insights
4 min read
Timolol: Detailed Review of its Transformative R&D Success
17 September 2023
This article summarized the latest R&D progress of Timolol, the Mechanism of Action for Timolol, and the drug target R&D trends for Timolol.
Latest Hotspot
4 min read
EyePoint Pharmaceuticals releases an encouraging safety update for EYP-1901 under PAVIA and DAVIO 2 Phase 2 Clinical Studies
17 September 2023
EyePoint Pharmaceuticals, Inc., a company focused on improving life quality for severe eye condition patients, has revealed promising safety data for its key product candidate EYP-1901.
Drug Insights
4 min read
Sulindac Unveiled: A Detailed Overview of its Revolutionary R&D Breakthroughs
17 September 2023
This article summarized the latest R&D progress of Sulindac, the Mechanism of Action for Sulindac, and the drug target R&D trends for Sulindac.
Valuable Targets
6 min read
CDK7 inhibitor - potential treatment strategy for multiple tumors
17 September 2023
CDK7 is a member of the cell cycle-dependent kinase (CDK) family, and a subunit of the multiprotein basal transcription factor TFIIH.
Drug Insights
4 min read
Unleashing the Power of Spinosad: A Comprehensive Review on R&D Breakthroughs
15 September 2023
This article summarized the latest R&D progress of Spinosad, the Mechanism of Action for Spinosad, and the drug target R&D trends for Spinosad.
Latest Hotspot
3 min read
Ifinatamab Deruxtecan Continues to Demonstrate Durable Responses in Patients with Advanced Small Cell Lung Cancer in Early Trial
15 September 2023
Updated results from a subgroup analysis of a phase 1/2 trial showed that ifinatamab deruxtecan (I-DXd) continues to demonstrate durable responses in patients with heavily pretreated advanced small cell lung cancer.
Drug Insights
4 min read
A Comprehensive Review of Somatostatin's R&D Innovations
15 September 2023
This article summarized the latest R&D progress of Somatostatin, the Mechanism of Action for Somatostatin, and the drug target R&D trends for Somatostatin.